Skip to main content

Key Product Details

Species Reactivity

Human

Applications

Western Blot, Immunoprecipitation

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

E. coli-derived recombinant human Latexin
Glu2-Glu222
Accession # AAH05346

Specificity

Detects human Latexin in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Human Latexin Antibody

Detection of Latexin by Flow Cytometry

Detection of Latexin by Flow Cytometry

IGFBP7 expression is up- and Latexin expression is downregulated in the xenograft melanoma induced by CEACAM1 kd cells. (A) IGFBP7 and Latexin expression are significantly regulated on the transcriptional level as determined by qRT-PCR with template cDNA derived from RNA from MeWo tumors (human melanoma cell line) subcutaneously grown in scid mice. Please note that lower Cp values mean higher levels of expression: IGFBP7 expression is significantly higher in MeWo CEACAM1 kd than in MeWo Luc control tumors whereas latexin expression is significantly lower in the MeWo CEACAM1 kd tumors. Each experiment was performed twice with 5 replicates each time. (B) Immunohistochemical staining of paraffin embedded tumor tissue (xenograft MeWo tumors in scid mice) for IGFBP7 and latexin demonstrated respective up- and downregulation of these two proteins. Little to no IGFBP7 (in red) could be shown in the MeWo Luc tumors (upper left panel) whereas high IGFBP7 was detected in the MeWo CEACAM1 kd tumors (lower left panel). Vice versa, high latexin expression could be detected in the MeWo Luc tumors (upper right panel) and little to no latexin expression in the CEACAM1 kd tumors (lower right panel). (C) IGFBP7 and latexin expression are up- and downregulated, respectively, on the cell culture level in MeWo CEACAM1 kd cells compared with MeWo Luc cells: Flow cytometric determination of intracellular IGFBP7 and latexin in MeWo Luc (teal curves) and MeWo CEACAM1 kd cells (orange curves) with corresponding isotype controls (black curves). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/30089785), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human Latexin Antibody

Application
Recommended Usage

Immunoprecipitation

25 µg/mL
Sample: Conditioned cell culture medium spiked with Recombinant Human Latexin (Catalog # 3246‑PI), see our available Western blot detection antibodies

Western Blot

0.1 µg/mL
Sample: Recombinant Human Latexin (Catalog # 3246‑PI)

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Latexin

Human Latexin, also known as tissue carboxypeptidase inhibitor, is the only mammalian carboxypeptidase inhibitor identified so far. Latexin was initially identified as a marker of neurons in the lateral neocortex of the developing brain (hence latexin) (1). Further studies have shown that latexin is highly expressed in mast cells and macrophages (2, 3). It is induced in acute pancreatitis and lung inflammatory disease. In addition, it is able to inhibit carboxypeptidases from the pancreas (CPA1 and CPA2) and mast cells (CPA3) (4). Therefore, it is thought that latexin primarily functions in inflammation and innate immunity pathways. Compared to other carboxypeptidase inhibitors from plants and parasites, the 222 amino acid latexin is much larger and more importantly, it lacks some conserved C-terminal residues, which interact with the target carboxypeptidase in a substrate-like manner (5). This distinct feature of latexin suggests that it has a different carboxypeptidase inhibition mechanism.

References

  1. Arimatsu, Y. et al. (1994) Neurosci. Res. 20:131.
  2. Uratani, Y. et al. (2000) Biochem. J. 346:817.
  3. Aagaard, A. et al. (2005) Structure 13:309.
  4. Normant, E. et al. (1995) Proc. Natl. Acad. Sci. USA 92:12225.
  5. Reverter, D. et al. (2000) Nat. Struct. Biol. 7:322.

Alternate Names

ECI, LXN, TCI

Entrez Gene IDs

56925 (Human); 17035 (Mouse); 59073 (Rat)

Gene Symbol

LXN

UniProt

Additional Latexin Products

Product Documents for Human Latexin Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human Latexin Antibody

For research use only

Loading...
Loading...
Loading...
Loading...